Suchergebnisse - "Cahn, Avivit"

PubPharm (145)

71

Validity of diagnostic codes and estimation of prevalence of diabetic foot ulcers using a large electronic medical record database

enthalten in: Diabetes/metabolism research and reviews | 2019

von Cahn, A. | Altaras, T. | Agami, T. | +7

72

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

enthalten in: The New England journal of medicine | 2019

von Wiviott, S. | Raz, I. | Bonaca, M. | +118

CommentIn: Nat Rev Cardiol. 2019 Jan;16(1):4. - PMID 30479387

73

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes : a systematic review and meta-analysis of cardiovascular outcome trials

enthalten in: Lancet (London, England) | 2019

von Zelniker, T. | Wiviott, S. | Raz, I. | +12

CommentIn: Lancet. 2019 Jan 5;393(10166):3-5. - PMID 30424891

74

Acute renal outcomes with sodium‐glucose co‐transporter‐2 inhibitors : Real‐world data analysis

enthalten in: Diabetes, Obesity and Metabolism | 2019

von Cahn, A. | Melzer‐Cohen, C. | Pollack, R. | +2

75

Clinical and Molecular Characteristics of Eight Israeli Families with Thyroid Hormone Receptor Beta Mutations

enthalten in: The Israel Medical Association journal : IMAJ | 2018

von Zaig, E. | Cohen-Ouaknine, O. | Tsur, A. | +6

76

Global status of diabetes prevention and prospects for action : A consensus statement

enthalten in: Diabetes/metabolism research and reviews | 2018

von Ibrahim, M. | Tuomilehto, J. | Aschner, P. | +12

77

Comparison of HBA1c Goals Proposed by an Algorithm To Those Set By Different Members of Healthcare Teams Within the Dartmouth Hitchcock Health System

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2018

von Delgado-Hurtado, J. | Cahn, A. | Raz, I. | +1

78

Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk

enthalten in: European heart journal | 2018

von Bergmark, B. | Scirica, B. | Steg, P. | +7

79

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial

enthalten in: American heart journal | 2018

von Wiviott, S. | Raz, I. | Bonaca, M. | +13

80

DECLARE-TIMI 58 : Participants' baseline characteristics

enthalten in: Diabetes, obesity & metabolism | 2018

von Raz, I. | Mosenzon, O. | Bonaca, M. | +12